Peripheral measurements of brain-derived neurotrophic factor and tropomyosin receptor kinase B provide the bases to study pathogenesis of neuropathic pain in diabetic polyneuropathy, and their action as biomarkers of the disease. This evidence concerns the gene BDNF and diabetic polyneuropathy.